Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

Recruiting now · Phase 4

Conditions studied: Metabolite

In brief

This is a 2-arm, prospective, randomized, parallel-group, open-label, longitudinal study that lasts 30 days for each study participant. This study aims to investigate the effect of co-administration of Omeprazole with Atorvastatin versus Atorvastatin monotherapy on atorvastatin lactone level. Primary endpoint: Higher statin lactone level in intervention arm after 30 days. Secondary endpoints: Higher hs-CRP in intervention arm Lipid panel Incidence of adverse drug side effects (e.g. muscle-related or elevated LFTs

Key facts

Study ID
NCT06690164
Run by
National University Hospital, Singapore
People needed
78
Starts
2025-06-12
Expected to finish
2026-06-01
Last updated by the study team
2025-07-02

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.